國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Identification and determination of ...

G�or�og, S.

Identification and determination of impurities in drugs

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Identification and determination of impurities in drugsedited by S�andor G�or�og.
其他作者:	G�or�og, S.
出版者:	Amsterdam ;Elsevier,2000.
面頁冊數:	xxiii, 748 p. :ill. ;23 cm.
標題:	DrugsAnalysis.
電子資源:	http://www.sciencedirect.com/science/book/9780444828996
ISBN:	9780444828996

Identification and determination of impurities in drugs
Identification and determination of impurities in drugs[electronic resource] /edited by S�andor G�or�og. - 1st ed. - Amsterdam ;Elsevier,2000. - xxiii, 748 p. :ill. ;23 cm. - Progress in pharmaceutical and biomedical analysis ;v. 4. - Progress in pharmaceutical and biomedical analysis ;v. 5..

Includes bibliographical references and index.

Chapter headings: Various Aspects of the Estimation of Impurities in Drugs. Identification, Structure Elucidation and Determination of Related Organic Impurities. Identification and Determination of Residual Solvents. Identification, Semiquantitative and Quantitative Determination of Inorganic Impurities. Degradation Products as Impurities. Determination of Enantiomeric Impurities. Estimation of Polymorphic Modifications as Impurities in Drugs. Microbiological Examination of Non-Sterile Drugs and Raw Materials. Selected Examples (Impurity Profiling of Some Groups of Drugs).

Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since this is the best way to characterise the quality and stability of bulk drugs and pharmaceutical formulations, this is the core activity in modern drug analysis. Due to the very rapid development of the analytical methodologies available for this purpose and the similarly rapid increase of the demands as regards the purity of drugs it is an important task to give a summary of the problems and the various possibilities offered by modern analytical chemistry for their solution. That is the aim of this book. The book is methodology-oriented. In the first chapter some important aspects of the background of impurity-related analytical studies (toxicological, pharmacopoeial aspects, the characterisation of the sources of impurities and the role of impurity profiling in various fields of drug research, production and therapeutic use) are summarised. Chapter two deals with related organic impurities, the strategies for impurity profiling, the use of chromatographic and related separation methods, spectroscopic, and hyphenated techniques. The subject of the third chapter is the identification and determination of residual solvents. The determination of inorganic impurities is discussed in chapter four. The special problems of degradation products as impurities are dealt with in chapter five. A separate chapter has been compiled to deal with one of the most up-to-date problems in contemporary pharmaceutical analysis, the estimation of enantiomeric purity of chiral drugs. Chapter seven is devoted to various approaches to solve the problem of polymorphic modifications as impurities. Since in the broader sense of the word the microbiological purity of drugs and drug products also belongs to this circle, the most important information from this field is summarised in chapter eight. After the mainly methodology-oriented chapters, the final one concentrates on four groups of drugs (peptides, biotechnological products, antibiotics and steroids) in order to demonstrate the use of the methods described earlier.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.

Mode of access: World Wide Web.

ISBN: 9780444828996

Source: 122768:127765Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

204967
Drugs
--Analysis.Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RS189 / .I29 2000eb

Dewey Class. No.: 615/.1901

National Library of Medicine Call No.: W1 / PR677LM v.4 2000

Identification and determination of impurities in drugs
LDR:04480cmm 2200397Ia 4500 001 288897
003 OCoLC
005 20110615082933.0
006 m d
007 cr cn|||||||||
008 110628s2000 ne a ob 001 0 eng d
020 $a 9780444828996
020 $a 0444828990
029 1 $a NZ1 $b 12432963
029 1 $a DEBSZ $b 316133140
035 $a (OCoLC)162130921
035 $a ocn162130921
037 $a 122768:127765 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $c OPELS $d DEBSZ $d OPELS
049 $a TEFA
050 1 4 $a RS189 $b .I29 2000eb
060 1 4 $a W1 $b PR677LM v.4 2000
060 1 4 $a QV 25 $b I19 2000
072 7 $a TP $2 lcco
082 0 4 $a 615/.1901 $2 22
245 0 0 $a Identification and determination of impurities in drugs $h [electronic resource] / $c edited by S�andor G�or�og.
250 $a 1st ed.
260 $a Amsterdam ; $a New York : $b Elsevier, $c 2000.
300 $a xxiii, 748 p. : $b ill. ; $c 23 cm.
490 1 $a Progress in pharmaceutical and biomedical analysis ; $v v. 4
504 $a Includes bibliographical references and index.
505 0 $a Chapter headings: Various Aspects of the Estimation of Impurities in Drugs. Identification, Structure Elucidation and Determination of Related Organic Impurities. Identification and Determination of Residual Solvents. Identification, Semiquantitative and Quantitative Determination of Inorganic Impurities. Degradation Products as Impurities. Determination of Enantiomeric Impurities. Estimation of Polymorphic Modifications as Impurities in Drugs. Microbiological Examination of Non-Sterile Drugs and Raw Materials. Selected Examples (Impurity Profiling of Some Groups of Drugs).
520 $a Impurity profiling is the common name of a group of analytical activities, the aim of which is the detection, identification/structure elucidation and quantitative determination of organic and inorganic impurities, as well as residual solvents in bulk drugs and pharmaceutical formulations. Since this is the best way to characterise the quality and stability of bulk drugs and pharmaceutical formulations, this is the core activity in modern drug analysis. Due to the very rapid development of the analytical methodologies available for this purpose and the similarly rapid increase of the demands as regards the purity of drugs it is an important task to give a summary of the problems and the various possibilities offered by modern analytical chemistry for their solution. That is the aim of this book. The book is methodology-oriented. In the first chapter some important aspects of the background of impurity-related analytical studies (toxicological, pharmacopoeial aspects, the characterisation of the sources of impurities and the role of impurity profiling in various fields of drug research, production and therapeutic use) are summarised. Chapter two deals with related organic impurities, the strategies for impurity profiling, the use of chromatographic and related separation methods, spectroscopic, and hyphenated techniques. The subject of the third chapter is the identification and determination of residual solvents. The determination of inorganic impurities is discussed in chapter four. The special problems of degradation products as impurities are dealt with in chapter five. A separate chapter has been compiled to deal with one of the most up-to-date problems in contemporary pharmaceutical analysis, the estimation of enantiomeric purity of chiral drugs. Chapter seven is devoted to various approaches to solve the problem of polymorphic modifications as impurities. Since in the broader sense of the word the microbiological purity of drugs and drug products also belongs to this circle, the most important information from this field is summarised in chapter eight. After the mainly methodology-oriented chapters, the final one concentrates on four groups of drugs (peptides, biotechnological products, antibiotics and steroids) in order to demonstrate the use of the methods described earlier.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2007. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on July 25, 2007). $n Access may be restricted to users at subscribing institutions.
650 0 $a Drugs $x Analysis. $3 204967
650 0 $a Contamination (Technology) $3 196373
650 0 $a Drug adulteration. $3 504906
650 6 $a Chimie pharmaceutique. $3 504907
650 6 $a M�edicaments $x Analyse. $3 504885
650 6 $a Pharmacologie. $3 504908
650 1 2 $a Pharmaceutical Preparations $x analysis. $3 214859
650 2 2 $a Chemistry, Analytical. $3 224793
650 2 2 $a Drug Contamination. $3 504909
655 7 $a Electronic books. $2 local. $3 214472
700 1 $a G�or�og, S. $3 504905
710 2 $a ScienceDirect (Online service) $3 307425
776 1 $c Original $z 0444828990 $z 9780444828996 $w (DLC) 00039379 $w (OCoLC)43905893
830 0 $a Progress in pharmaceutical and biomedical analysis ; $v v. 5. $3 504881
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780444828996
994 $a C0 $b TEF